Global Scans · Cancer · Weekly Summary

• [New] Along with age, smoking status and previous history of lung disease, the machine learning algorithm identified 14 key proteins in the blood that could predict a future diagnosis of lung cancer within five years. WEHI
• [New] Landmark study co-led by the Crick Institute and UCL identifies a 14-protein blood signature that can predict lung cancer risk more than five years before diagnosis. WEHI
• [New] In a population-based case-control study in Shanghai, China, consumption of green tea was associated with a reduced risk of lung cancer among non-smoking women and the risk decreased with increasing consumption. PubMed Central (PMC)
• Researchers at NYU Grossman School of Medicine and NYU's Center for Data Science developed a multimodal artificial intelligence test that may predict breast cancer recurrence faster and more affordably than current genomic assays. NYU Langone News
• Sustained reductions in mortality for CRC, the second-most common cause of cancer death in men and women combined, are the result of changing patterns in risk factors (e.g., declines in smoking), screening uptake, and improved treatment. Ovid
• J&J has openly said it wants to become the world's top cancer drugmaker by 2030, targeting $50 billion in oncology revenue by then. TU News
• The integration of algorithmic screening tools in mammography and lung cancer screening programs has demonstrated the potential to increase early detection rates by up to 15% compared to conventional methods alone. Market Data Forecast
• About 1 in 9 men and 1 in 13 women are expected to die from cancer, while annual cases are projected to reach 34 million by 2050, a 67% increase driven solely by population growth and ageing. SciTechDaily
• For roughly one in five people worldwide, cancer will become part of their lifetime. SciTechDaily
• The PROTEUS trial establishes perioperative apalutamide plus Androgen Deprivation Therapy (ADT) as a new standard for high-risk localized prostate cancer; important caveats about patient selection and cardiovascular risk apply. The Cancer News
• While prevention is key to reducing cancer rates, we need to recognise that nearly 1 in 2 Australians will be affected by cancer in their lifetime. Cancer Council Australia
• Enter COMPASS, a new pan-cancer AI model introduced in Nature Medicine that analyzes tumour gene expression to forecast immunotherapy success across 33 cancer types and multiple immune checkpoint inhibitors. This Week in Science
• Over the next five to ten years, AI will achieve, among other things, the reliable prevention and treatment of nearly all natural infectious disease, the elimination of most cancer, the prevention of Alzheimer's and a doubling of the human lifespan. Forbes
• A new WHO report projects annual cancer cases could rise from 20.6 million to nearly 35 million by 2050 unless urgent action is taken. Access Information News

Last updated: 02 August 2026